Buthalital
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEMBL | |
Chemical and physical data | |
Formula | C11H15N2NaO2S |
Molar mass | 262.304 g/mol |
3D model (JSmol) | |
| |
|
Buthalital sodium (INN; Bayinal, Baytinal, Thialbutal, Transithal, Ulbreval), or buthalitone sodium (BAN), is a barbiturate derivative which was under development as a short-acting anesthetic.[1][2] However, development was discontinued, perhaps due to its extremely rapid elimination rate,[3] and buthalital sodium was never marketed.[1]
See also
References
- 1 2 F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 338. ISBN 978-0-412-46630-4. Retrieved 19 May 2012.
- ↑ Martin, J. R.; Godel, T.; Hunkeler, W.; Jenck, F.; Moreau, J.-L.; Sleight, A. J.; Widmer, U. (2000). "Psychopharmacological Agents". doi:10.1002/0471238961.1619250313011820.a01.
- ↑ Wollweber, Hartmund (2000). "Anesthetics, General". doi:10.1002/14356007.a02_289.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.